RNA, U6 small nuclear 284, pseudogene (RNU6-284P)

RNU6-284P (RNA, U6 small nuclear 284, pseudogene) is a non-protein-coding genetic element categorized as a small nuclear RNA (snRNA) pseudogene. It is similar in sequence to functional U6 snRNA genes, which play a central role in the spliceosome by catalyzing pre-mRNA splicing, but RNU6-284P itself is not believed to produce a functional RNA molecule. Like other U6 pseudogenes, it retains homology with true U6 sequences but typically arises via genomic duplication or retrotransposition events and does not contribute directly to spliceosome activity or other known cellular functions[4][6][7]. There is no evidence that RNU6-284P has biological activity, therapeutic relevance, or is implicated in disease. Its designation as a pseudogene means it is not, by itself, a valid drug target or biomarker, nor does it interact with known drugs. Key context: - RNU6-284P is one of many U6 snRNA pseudogenes found throughout the genome[5][6]. - Unlike true U6 snRNA (such as the canonical U6 spliceosomal RNA), pseudogenes like RNU6-284P are typically non-functional remnants of duplications or retrotransposed events[5][6]. - There is no evidence suggesting this pseudogene is transcribed into a functionally relevant RNA or that it has a role in disease, cellular physiology, or therapeutic targeting. Summary statement: RNU6-284P is a pseudogene (non-functional copy) of the U6 small nuclear RNA gene family, not a functional target, enzyme, receptor, or therapeutic molecule, and thus should not be classified as a druggable or therapeutic target[4][5][6][7].

Other names

RNU6-284PRNA, U6 Small Nuclear 284, Pseudogene